Financing translation: Analysis of the NCATS rare-diseases portfolio

Financing translation: Analysis of the NCATS rare-diseases portfolio

The portfolio of the National Center for Advancing Translational Sciences (NCATS) rare-diseases therapeutic development program comprises 28 research projects initiated at the preclinical stage. Historical data reveal substantially lower costs and higher success rates but longer preclinical timeline...

Full description

Bibliographic Details
Main Authors: Fagnan, David E., Yang, N. Nora, McKew, John C., Lo, Andrew W
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Format: Article
Language:en_US
Published: American Association for the Advancement of Science (AAAS) 2015
Online Access:http://hdl.handle.net/1721.1/99456
https://orcid.org/0000-0003-2944-7773

Internet

http://hdl.handle.net/1721.1/99456
https://orcid.org/0000-0003-2944-7773

Similar Items